Anatol J Cardiol. 2023; 27(7): 417-422 | DOI: 10.14744/AnatolJCardiol.2023.2719 | |||
Relationship Between Urinary Angiotensinogen and Mortality in Patients with Heart Failure with Reduced Ejection FractionÖzcan Örsçelik1, Emrah Yeşil1, Hakan Uyar2, Ali Orçun Sürmeli3, Buğra Özkan1, Mehmet Burak Yavuz Çimen41Department of Cardiology, Faculty of Medicine, Mersin University, Mersin, Turkey2Department of Cardiology, Mersin City Training and Research Hospital, Mersin, Turkey 3Department of Cardiology, Tarsus State Hospital, Mersin, Turkey 4Department of Medical Biochemistry, Faculty of Medicine, Mersin University, Mersin, Turkey Background: Activation of the reninangi otens in-aldosterone system has an important role in the pathophysiology of heart failure with reduced ejection fraction. While the effects of systemic reninangi otens in-aldosterone system activation on heart failure with reduced ejection fraction are well known, the impact of the local reninangi otens in-aldosterone system on heart failure with reduced ejection fraction is not fully understood because of limited clinical research. This study aimed to investigate the effect of urinary angiotensinogen level, an accepted indicator of local reninangi otens in-aldosterone system activation, on all-cause mortality in patients with heart failure with reduced ejection fraction. Özcan Örsçelik, Emrah Yeşil, Hakan Uyar, Ali Orçun Sürmeli, Buğra Özkan, Mehmet Burak Yavuz Çimen. Relationship Between Urinary Angiotensinogen and Mortality in Patients with Heart Failure with Reduced Ejection Fraction. Anatol J Cardiol. 2023; 27(7): 417-422 Corresponding Author: Emrah Yeşil, Türkiye |
|